Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-01 Sale |
2022-03-02 9:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,123 | $19.73 | $61,617 | 213,960 (Direct) |
View |
| 2022-02-15 Sale |
2022-02-17 4:34 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,123 | $18.64 | $58,213 | 123,583 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-03 4:30 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,123 | $18.79 | $58,681 | 126,706 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-20 4:47 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
4,168 | $23.29 | $97,073 | 128,875 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-06 4:37 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
7,168 | $28.02 | $200,847 | 133,043 (Direct) |
View |
| 2021-12-28 Sale |
2021-12-30 7:19 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,000 | $27.95 | $83,852 | 140,211 (Direct) |
View |
| 2021-12-15 Sale |
2021-12-17 4:28 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
5,668 | $24.14 | $136,826 | 143,211 (Direct) |
View |
| 2021-12-01 Sale |
2021-12-03 4:36 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
5,668 | $27.38 | $155,190 | 148,879 (Direct) |
View |
| 2021-11-15 Sale |
2021-11-17 5:01 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
7,168 | $27.01 | $193,574 | 154,547 (Direct) |
View |
| 2021-11-05 Sale |
2021-11-09 5:44 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
16,500 | $28.06 | $463,041 | 161,715 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 4:57 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
5,668 | $24.79 | $140,510 | 178,215 (Direct) |
View |
| 2021-10-27 Sale |
2021-10-28 5:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,000 | $24 | $71,991 | 183,883 (Direct) |
View |
| 2021-10-21 Sale |
2021-10-25 4:28 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
1,042 | $21.1 | $21,984 | 186,883 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-28 Option Award |
2022-03-02 9:00 pm |
N/A 2032-02-27 |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
93,500 | $0 | 213,960 (Direct) |
View |
Ownership |
2021-10-19 4:54 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
0 | $0 | 677,730 (Direct) |
View |